Psagot Value Holdings’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-3,744
| Closed | -$7K | – | 599 |
|
2023
Q1 | $7K | Sell |
3,744
-2,256
| -38% | -$4.22K | ﹤0.01% | 312 |
|
2022
Q4 | $8K | Hold |
6,000
| – | – | ﹤0.01% | 328 |
|
2022
Q3 | $6K | Hold |
6,000
| – | – | ﹤0.01% | 318 |
|
2022
Q2 | $7K | Hold |
6,000
| – | – | ﹤0.01% | 273 |
|
2022
Q1 | $6K | Hold |
6,000
| – | – | ﹤0.01% | 299 |
|
2021
Q4 | $5K | Hold |
6,000
| – | – | ﹤0.01% | 329 |
|
2021
Q3 | $8K | Hold |
6,000
| – | – | ﹤0.01% | 375 |
|
2021
Q2 | $11K | Sell |
6,000
-3,089,741
| -100% | -$5.66M | ﹤0.01% | 397 |
|
2021
Q1 | $13.8M | Buy |
3,095,741
+2,625,486
| +558% | +$11.7M | 0.31% | 83 |
|
2020
Q4 | $1.71M | Hold |
470,255
| – | – | 0.04% | 149 |
|
2020
Q3 | $1.82M | Hold |
470,255
| – | – | 0.05% | 132 |
|
2020
Q2 | $1.73M | Buy |
470,255
+63,900
| +16% | +$235K | 0.05% | 120 |
|
2020
Q1 | $955K | Buy |
406,355
+406,255
| +406,255% | +$955K | 0.04% | 138 |
|
2019
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 457 |
|
2019
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 423 |
|
2019
Q2 | $0 | Sell |
100
-3,036
| -97% | – | ﹤0.01% | 443 |
|
2019
Q1 | $14K | Sell |
3,136
-31
| -1% | -$138 | ﹤0.01% | 403 |
|
2018
Q4 | $10K | Buy |
3,167
+118
| +4% | +$373 | ﹤0.01% | 403 |
|
2018
Q3 | $22K | Sell |
3,049
-45
| -1% | -$325 | ﹤0.01% | 327 |
|
2018
Q2 | $13K | Buy |
3,094
+165
| +6% | +$693 | ﹤0.01% | 309 |
|
2018
Q1 | $15K | Buy |
2,929
+10
| +0.3% | +$51 | ﹤0.01% | 306 |
|
2017
Q4 | $20K | Sell |
2,919
-339
| -10% | -$2.32K | ﹤0.01% | 266 |
|
2017
Q3 | $19K | Buy |
3,258
+91
| +3% | +$531 | ﹤0.01% | 285 |
|
2017
Q2 | $26K | Buy |
3,167
+962
| +44% | +$7.9K | ﹤0.01% | 275 |
|
2017
Q1 | $30K | Sell |
2,205
-20
| -0.9% | -$272 | ﹤0.01% | 289 |
|
2016
Q4 | $10K | Buy |
2,225
+20
| +0.9% | +$90 | ﹤0.01% | 307 |
|
2016
Q3 | $13K | Hold |
2,205
| – | – | ﹤0.01% | 304 |
|
2016
Q2 | $14K | Sell |
2,205
-6,319
| -74% | -$40.1K | ﹤0.01% | 287 |
|
2016
Q1 | $72K | Sell |
8,524
-1,664
| -16% | -$14.1K | ﹤0.01% | 290 |
|
2015
Q4 | $103K | Buy |
10,188
+1,478
| +17% | +$14.9K | ﹤0.01% | 287 |
|
2015
Q3 | $103K | Sell |
8,710
-3,540
| -29% | -$41.9K | ﹤0.01% | 281 |
|
2015
Q2 | $239K | Buy |
12,250
+5,057
| +70% | +$98.7K | 0.01% | 237 |
|
2015
Q1 | $128K | Hold |
7,193
| – | – | ﹤0.01% | 272 |
|
2014
Q4 | $132K | Hold |
7,193
| – | – | ﹤0.01% | 279 |
|
2014
Q3 | $174K | Hold |
7,193
| – | – | 0.01% | 233 |
|
2014
Q2 | $263K | Hold |
7,193
| – | – | 0.01% | 207 |
|
2014
Q1 | $329K | Sell |
7,193
-255
| -3% | -$11.7K | 0.01% | 221 |
|
2013
Q4 | $290K | Buy |
7,448
+4,987
| +203% | +$194K | 0.01% | 243 |
|
2013
Q3 | $111K | Hold |
2,461
| – | – | ﹤0.01% | 327 |
|
2013
Q2 | $121K | Buy |
+2,461
| New | +$121K | 0.01% | 239 |
|